Beta-2-Microglobulin Levels in Nasopharyngeal Carcinoma
Author Information
Author(s): W. Shiu, S.F. Leung, W.T. Leung, S. Ho, M. Tao
Primary Institution: Chinese University of Hong Kong at Prince of Wales Hospital
Hypothesis
The study investigates the relationship between serum beta-2-microglobulin levels and the stage of nasopharyngeal carcinoma.
Conclusion
Serum beta-2-microglobulin levels increase with the advancing stage of nasopharyngeal carcinoma, but its sensitivity for diagnosis is low.
Supporting Evidence
- Beta-2-microglobulin levels were found to increase with advancing stage of nasopharyngeal carcinoma.
- Significant differences in mean levels of beta-2-microglobulin were observed between metastatic and other stages.
- The sensitivity of serum beta-2-microglobulin for detecting nasopharyngeal carcinoma was only 37%.
Takeaway
Doctors checked a protein called beta-2-microglobulin in patients with throat cancer, and they found that higher levels of this protein usually mean the cancer is more advanced.
Methodology
Serum samples were collected from patients and healthy volunteers, and beta-2-microglobulin levels were measured using radioimmunoassay.
Limitations
The sensitivity of serum beta-2-microglobulin for diagnosing nasopharyngeal carcinoma is low.
Participant Demographics
Chinese patients with nasopharyngeal carcinoma and healthy volunteers.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website